Titlebook: Cancer; Robert H. Bradbury Book 2007 Springer-Verlag Berlin Heidelberg 2007 Cancer.Chemotherapy.Tumour.angiogenesis.biology.chemistry.medi

心胸狭窄

https://doi.org/10.1007/978-3-540-33120-9Cancer; Chemotherapy; Tumour; angiogenesis; biology; chemistry; medicinal chemistry; tumorigenesis

温室

CLAY

Robert H. BradburyIn each volume an overview chapter introduces the newcomer to the topic covered.Series covers hot topics of frontier research summarized by reputed scientists in the field.Review series is topic relat

SAGE

象形文字

走路左晃右晃

1862-2461 Overview: In each volume an overview chapter introduces the newcomer to the topic covered.Series covers hot topics of frontier research summarized by reputed scientists in the field.Review series is topic relat978-3-642-06966-6978-3-540-33120-9Series ISSN 1862-2461 Series E-ISSN 1862-247X

显示

Masamitsu Shimazawa,Hideaki Harars which include limitations of animal models,tumour diversity, drug resistance and side effects of therapy. This introductory overview gives a briefperspective on the discovery of historical cytotoxic and anti-hormonal drugs, and then highlights the shiftin research emphasis over the last 15 years

fleeting

GLUE

Original

https://doi.org/10.1007/978-4-431-54502-6l-molecule inhibitors that could be developedas oral therapeutics. There are now several farnesyl protein inhibitors (FTIs) in various phases of clinicaldevelopment and at least two compounds have entered phase III. The published data suggest some disappointingactivity in the major solid tumors, wit